EUVIMEDEUVIMED entdecken
Crossref

From Lab to Home: Ultrasensitive Rapid Detection of SARS-CoV-2 with a Cascade CRISPR/Cas13a-Cas12a System Based Lateral Flow Assay

Ronghuan Hu, Chuanghao Guo, Conghui Liu, Qianling Zhang iD, Xueji Zhang iD, Yong Chen, Yizhen Liu iD

Analytical Chemistry · 03.09.2024 · 96 (35) · 14197-14204

DOI: 10.1021/acs.analchem.4c02726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 20.08.2024. Verfasst von Ronghuan Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, College of Chemistry and Environmental Engineering, Shenzhen University, …. Hauptthemen laut MEDLINE: SARS-CoV-2, CRISPR-Cas Systems, RNA, Viral, COVID-19. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Shenzhen Science and Technology Innovation Commission, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, CRISPR/Cas-based molecular diagnostic techniques usually rely on the introduction of nucleic acid amplification to improve their sensitivity, which is usually more time-consuming, susceptible to aerosol contamination, and therefore not suitable for at-home molecular testing. In this research, we developed an advanced CRISPR/Cas13a-Cas12a-based lateral flow assay that facilitated the ultrasensitive and rapid detection of SARS-CoV-2 RNA directly from samples, without the need for nucleic acid amplification. This method was called CRISPR LFA enabling at-home RNA testing (CLEAR). CLEAR used a novel cascade mechanism with specially designed probes that fold into hairpin structures, enabling visual detection of SARS-CoV-2 sequences down to 1 aM sensitivity levels. More importantly, CLEAR had a positive coincidence rate of 100% and a negative coincidence rate of 100% for clinical nasopharyngeal swabs from 16 patients. CLEAR was particularly suitable for at-home molecular testing, providing a low-cost, user-friendly solution that can efficiently distinguish between different SARS-CoV-2 variants. CLEAR overcame the common limitations of high sensitivity and potential contamination associated with traditional PCR-based systems, making it a promising tool for widespread public health application, especially in environments with limited access to laboratory resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2CRISPR-Cas SystemsRNA, ViralCOVID-19HumansCOVID-19 Nucleic Acid TestingNucleic Acid Amplification TechniquesMolecular Diagnostic TechniquesLimit of Detection

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, Guangdong, People's Republic of China.
  • Shenzhen Key Laboratory of Nano-Biosensing Technology, Shenzhen 518060, Guangdong, People's Republic of China.
  • Environmental Engineering and Graphene Composite, Research Center, College of Chemistry and Environmental, Engineering, Shenzhen University, Shenzhen 518060, Guangdong, People's Republic of China.

ORCID-Profile: Qianling Zhang, Xueji Zhang, Yizhen Liu

Förderung

  • Shenzhen Science and Technology Innovation Commission
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Special Foundation for State Major Research Program of China

Zitieren

APA

Hu, R., Guo, C., Liu, C., Zhang, Q., Zhang, X., Chen, Y., & Liu, Y. (2024). From Lab to Home: Ultrasensitive Rapid Detection of SARS-CoV-2 with a Cascade CRISPR/Cas13a-Cas12a System Based Lateral Flow Assay. Analytical Chemistry, 96(35), 14197-14204. https://doi.org/10.1021/acs.analchem.4c02726

Vancouver

Hu R, Guo C, Liu C, Zhang Q, Zhang X, Chen Y, et al. From Lab to Home: Ultrasensitive Rapid Detection of SARS-CoV-2 with a Cascade CRISPR/Cas13a-Cas12a System Based Lateral Flow Assay. Analytical Chemistry. 2024;96(35):14197-14204. doi:10.1021/acs.analchem.4c02726

BibTeX
@article{Hu2024,
  author = {Hu, Ronghuan and Guo, Chuanghao and Liu, Conghui and Zhang, Qianling and Zhang, Xueji and Chen, Yong and Liu, Yizhen},
  title = {From Lab to Home: Ultrasensitive Rapid Detection of SARS-CoV-2 with a Cascade CRISPR/Cas13a-Cas12a System Based Lateral Flow Assay},
  journal = {Analytical Chemistry},
  year = {2024},
  volume = {96},
  number = {35},
  pages = {14197--14204},
  doi = {10.1021/acs.analchem.4c02726}
}
Kostenlos starten →